Copyright: ©Author(s) 2026.
World J Diabetes. Apr 15, 2026; 17(4): 117063
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.117063
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.117063
Figure 2 Levels of C-reactive protein, fasting C-peptide, and the C-reactive protein-fasting C-peptide product stratified by sex, age, and duration of diabetes.
A-C: Serum C-reactive protein (CRP) levels stratified by sex (A), age (B), and duration of diabetes (DD; C); D-F: Serum fasting C-peptide (FCP) levels stratified by sex (D), age (E), and DD (F); G-I: CRP-FCP product levels stratified by sex (G), age (H), and DD (I). CRP: C-reactive protein; FCP: Fasting C-peptide; DD: Duration of diabetes.
- Citation: Zhang YW, Xu MR, Li MH, Li LX. Product of C-reactive protein and fasting C-peptide indicates cardiovascular risk in type 2 diabetes: A real-world study. World J Diabetes 2026; 17(4): 117063
- URL: https://www.wjgnet.com/1948-9358/full/v17/i4/117063.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i4.117063